HOME >> BIOLOGY >> NEWS
Leading U.S. gun manufacturer joins NJIT to develop personalized handgun

Newark, Nov. 26 - An agreement to form a trilateral partnership to develop a unique personalized handgun was signed by New Jersey Institute of Technology (NJIT), Taurus International Manufacturing, Inc., Florida, and the Australian-based research and development company Metal Storm, Ltd.

"We are delighted to include Taurus in our development team" said Donald H. Sebastian, Ph.D., vice president for research and development at New Jersey Institute of Technology (NJIT), Newark. Metal Storm and NJIT signed an agreement earlier this year creating the initial team. "The addition of a commercial producer to our technology partnership is vital to ensuring that our design reflects the combined influences of efficient manufacturing practice and consumer preferences. By working prototype and commercial product design in parallel we will shave years off the development cycle."

The partners will create a handgun that will instantly and reliably recognize its authorized operators. The new firearm will combine the developed and patented Dynamic Grip Recognition technology owned by NJIT with the patented handgun Electronic Firing System owned by Metal Storm Ltd. Taurus International Manufacturing, Inc. Florida, and Forjas Taurus, Brazil, will design a total handgun package to house the two new technologies.

The NJIT project picked up speed last spring when NJIT Associate Professor of Information Systems Michael Recce, Ph.D., received a patent for his behavioral biometric, Dynamic Grip Recognition. Recce's invention enabled NJIT researchers to embed multiple small electronic sensors in both sides of a gun's handle to identify the user. Recce sees his invention someday being used in other applications--perhaps the yoke of a plane or the steering wheel of a car.

In New Jersey, the project to develop a personalized weapon, better known as smart gun, has been an ongoing effort since the spring of 2000 when NJIT received the support of the
'"/>

Contact: Sheryl Weinstein
weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
26-Nov-2003


Page: 1 2 3

Related biology news :

1. Leading scientists design new framework for biodiversity conservation
2. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
3. Leading experts in field of gene therapy to meet in Minneapolis
4. Leading bacterial pathogen is sequenced
5. Leading cloning experts challenge Clonaid to prove claim
6. Leading cancer research organization urges FDA to speed approval of drugs for precancers
7. Leading lab expert to update medical community on diagnostic testing for thyroid function
8. Leading indoor environment experts to convene at Syracuse University to discuss air quality and urban environments
9. Leading snake expert dies at 38
10. Leading experts address safety and economics of biotech crops
11. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students

Post Your Comments:
(Date:7/23/2014)... drought that has the entire country in its grip is ... also be responsible for the proliferation of a heat-loving amoeba ... and hot springs, which the drought has made warmer than ... of an infection caused by this parasite after swimming in ... nose of an individual and travels to the brain. Nose ...
(Date:7/23/2014)... The Worldwide Innovative Networking in personalized cancer medicine, ... Cancer Center at Thomas Jefferson University will ... only member of this prestigious group in the Tri-State ... delivery of innovative personalized medicine to the patient by ... advocacy. , "Our participation in the WIN consortium means ...
(Date:7/23/2014)... play an increasingly important role in carbon and nutrient ... expand, according to research published this week in the ... , University of British Columbia researchers plumbed the depth ... chart how microbial community metabolism changes as oxygen minimum ... picture of how SUP05 a bacterial group related ...
Breaking Biology News(10 mins):Diseases of another kind 2New partnership brings more personalized cancer treatment to Philadelphia 2Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
(Date:7/23/2014)... the right people at the table for significant business ... achieving clinical and operational goals. The 22 nd ... 2014, in San Diego , featured ... discussing how partnerships have positively impacted their objectives. ... Officer of Cape Regional Medical Center located in ...
(Date:7/23/2014)... , July 23, 2014 ... portfolio company of Trendlines Agtech , announced ... Israel,s leading agricultural thermoplastics ... Valentis,s technology combines nanocrystalline cellulose (NCC), ... waste, with additional nanoparticles to produce highly improved ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
(Date:7/23/2014)... July 23, 2014  Sofinnova Ventures, a ... the closing of Sofinnova Venture Partners IX, L.P. at ... of the initial fund target of $425 million. ... biotechnology companies. Consistent with recent funds, SVP IX will ... clinical programs, along with select investments in earlier stage ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2
Cached News: